Total entries:  5

DRACPC0013

Active Ingredients:  Lutetium Lu 177 dotatate

Type:  Small Molecule

Active Sequence:  Not available

Molecular Formula: C65H87LuN14O19S2

DrugBank Accession Number:  DB13985

PubChem CID:  76966897

NCI Thesaurus Code:  C95020  

Disease: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

DRACPC0020

Active Ingredients:  Gallium Ga-68 gozetotide

Type:  Small Molecule

Active Sequence:  Not available

Molecular Formula: C44H59GaN6O17

DrugBank Accession Number:  DB16019

PubChem CID:  154572876

NCI Thesaurus Code:  C118961  

Disease: Prostatic Neoplasms

DRACPC0028

Active Ingredients:  Lutetium Lu-177 vipivotide tetraxetan

Type:  Small Molecule

Active Sequence:  Not available

Molecular Formula: C49H68LuN9O16

DrugBank Accession Number:  DB16778

PubChem CID:  122706785

NCI Thesaurus Code:  C148145  

Disease: Metastatic Castration-Resistant Prostate Cancer (mCRPC)

DRACPC0054

Active Ingredients:  18F-DCFBC

Type:  Small Molecule

Active Sequence:  Not available

Molecular Formula: C16H19FN2O7S

DrugBank Accession Number:  DB14772

PubChem CID:  25067411

NCI Thesaurus Code:  C96234  

Disease: Prostatet cancer

DRACPC0080

Active Ingredients:  Iofolastat I-123

Type:  Small Molecule

Active Sequence:  Not available

Molecular Formula: C19H26IN3O7

DrugBank Accession Number:  DB12514

PubChem CID:  25194767

NCI Thesaurus Code:  Not available

Disease: Prostate Cancer

<< < 1 >>

DRACP is developed by Dr.Zheng's team.